Delivery Order SPE2DB22D2005-SPE2DB24FJFK4
Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,873.72 firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply Pfizer's COVID-19 vaccines for the 2023-2024 period. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 16, 2023. No set-aside designation was applied to this order, which was issued against the DLA's indefinite-delivery contract vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,291.24 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Pfizer's COVID-19 vaccines for the 2023-2024 period. The delivery order was issued against an existing indefinite delivery contract with no set-aside designation specified. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 21,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,081.35 firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply Pfizer's COVID-19 vaccines for the 2023-2024 period. The delivery order was issued against an existing indefinite delivery contract with no set-aside designation specified. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 14, 2023. As a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $4,928.25 firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply Pfizer's COVID-19 vaccines for the 2023-2024 period. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 6, 2023. No set-aside designation was applied to this award made under the DLA's indefinite-delivery contract vehicle. As a leading...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,135.77 from the Defense Logistics Agency (DLA) to supply 6 million to 4 years' worth of 0.9mL doses of Pfizer's COVID-19 vaccine under emergency use authorization. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all doses required to be delivered by December 15, 2023. This order was awarded against an indefinite delivery contract between Amerisourcebergen Drug...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order worth $2,271.56 from the Defense Logistics Agency (DLA) to supply 6 million to 4 years' worth of 0.9mL doses of Pfizer's COVID-19 vaccine under emergency use authorization. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 19, 2023. No set-aside designation was applied to this order issued against an indefinite-delivery contract between Amerisourcebergen Drug Corp...
- Amerisourcebergen Drug Corp has received a $1,135.77 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 6 million to 4 years' worth of 0.9mL doses of Pfizer's COVID-19 vaccine under emergency use authorization. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by December 11, 2023. No set-aside designation was applied to this award made against an unmentioned indefinite...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at $17,036.55 from the Defense Logistics Agency (DLA) to supply 6 million to 4 years' worth of 0.9ml doses of Pfizer's COVID-19 vaccine under emergency use authorization. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 16, 2023 with no set-aside designation used. As a leading pharmaceutical distributor, Amerisourcebergen utilizes its Corporate Office...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at $1,291.24 from the Defense Logistics Agency (DLA) to supply Pfizer's COVID-19 vaccine under emergency use authorization. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania through November 2023. As a prime contractor and distributor of pharmaceuticals, Amerisourcebergen routinely supplies medical products to DLA Troop Support Medical facilities in support of military...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,873.72 firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply an estimated 6 million to 4 year's worth of 0.9mL doses of Pfizer's COVID-19 vaccine under emergency use authorization. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by November 20, 2023. No set-aside designation was applied to this...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJFK4Delivery Order
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,135.77 to supply Pfizer's COVID-19 vaccines for 2023-2024. The order was awarded on December 12, 2023 with performance at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 13, 2023. As a leading pharmaceutical distributor, Amerisourcebergen will deliver approximately 6 million to 4 million doses of the 0.9mL Pfizer COVID-19 vaccine to support DLA's medical treatment programs. No set-aside designation was applied to this order placed under the parent company Cencora, Inc.'s indefinite delivery contract with DLA Troop Support Medical.
Generated 3/12/24, 10:33 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/12/23 |